Galon, J., Mlecnik, B., Hermitte, F., Marliot, F., Bifulco, C., Lugli, A., . . . Pagès, F. (2018). 12PMSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies. Annals of Oncology, 29, N.PAG. https://doi.org/10.1093/annonc/mdy493.011
Chicago Style (17th ed.) CitationGalon, J., et al. "12PMSI Status Plus Immunoscore to Select Metastatic Colorectal Cancer Patients for Immunotherapies." Annals of Oncology 29 (2018): N.PAG. https://doi.org/10.1093/annonc/mdy493.011.
MLA (9th ed.) CitationGalon, J., et al. "12PMSI Status Plus Immunoscore to Select Metastatic Colorectal Cancer Patients for Immunotherapies." Annals of Oncology, vol. 29, 2018, p. N.PAG, https://doi.org/10.1093/annonc/mdy493.011.
Warning: These citations may not always be 100% accurate.